These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38443311)

  • 1. Natural history and biomarkers of KCNV2-associated retinopathy.
    Sakti DH; Cornish EE; Ali H; Retsas S; Raza M; Saakova N; Carvalho LS; Nash BM; Jamieson RV; Grigg JR
    Clin Exp Ophthalmol; 2024 Jul; 52(5):528-544. PubMed ID: 38443311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel KCNV2 mutation in a patient taking hydroxychloroquine associated with cone dystrophy with supernormal rod response.
    Liu PK; Ryu J; Yeh LK; Chen KJ; Tsang SH; Liu L; Wang NK
    Ophthalmic Genet; 2021 Aug; 42(4):458-463. PubMed ID: 33960280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course of two siblings with potassium voltage-gated channel modifier subfamily V member 2 (KCNV2)-associated retinopathy.
    Sato T; Kuniyoshi K; Hayashi T; Nishiwaki H; Mizobuchi K; Kusaka S
    Doc Ophthalmol; 2024 Jun; 148(3):173-182. PubMed ID: 38630375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-color pupillometry in KCNV2 retinopathy.
    Collison FT; Park JC; Fishman GA; Stone EM; McAnany JJ
    Doc Ophthalmol; 2019 Aug; 139(1):11-20. PubMed ID: 30927187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of a Chinese patient with
    Lie H; Wang G; Liu X; Meng X; Long Y; Ren J; Yang L; Fujinami-Yokokawa Y; Kurihara T; Tsubota K; Fujinami K; Li S
    Ophthalmic Genet; 2021 Apr; 42(2):144-149. PubMed ID: 33372566
    [No Abstract]   [Full Text] [Related]  

  • 6. Cone dystrophy with supernormal rod responses: A rare KCNV2 gene variant.
    Esteves-Leandro J; Torres-Costa S; Estrela-Silva S; Santos-Silva R; Brandão E; Grangeia A; Fernandes S; Oliveira R; Falcão-Reis F; Rocha-Sousa A
    Eur J Ophthalmol; 2022 Jan; 32(1):664-672. PubMed ID: 33706576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2.
    Wissinger B; Dangel S; Jägle H; Hansen L; Baumann B; Rudolph G; Wolf C; Bonin M; Koeppen K; Ladewig T; Kohl S; Zrenner E; Rosenberg T
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):751-7. PubMed ID: 18235024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution optical coherence tomography imaging in KCNV2 retinopathy.
    Sergouniotis PI; Holder GE; Robson AG; Michaelides M; Webster AR; Moore AT
    Br J Ophthalmol; 2012 Feb; 96(2):213-7. PubMed ID: 21558291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fundus autofluorescence, optical coherence tomography and electroretinography abnormalities in a patient with digoxin retinopathy that resemble those in KCNV2-associated retinopathy.
    Nagae Y; Kuniyoshi K; Ishibashi M; Tanabe F; Matsumoto C; Kusaka S
    Doc Ophthalmol; 2023 Oct; 147(2):131-137. PubMed ID: 37460904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CENTRAL ELLIPSOID LOSS ASSOCIATED WITH CONE DYSTROPHY AND KCNV2 MUTATION.
    Xu D; Su D; Nusinowitz S; Sarraf D
    Retin Cases Brief Rep; 2018 Fall; 12 Suppl 1():S59-S62. PubMed ID: 29210963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic characteristics including in vivo cone photoreceptor mosaic in KCNV2-related "cone dystrophy with supernormal rod electroretinogram".
    Vincent A; Wright T; Garcia-Sanchez Y; Kisilak M; Campbell M; Westall C; Héon E
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):898-908. PubMed ID: 23221069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Cone dystrophy with supernormal rod electroretinogram": a comprehensive genotype/phenotype study including fundus autofluorescence and extensive electrophysiology.
    Robson AG; Webster AR; Michaelides M; Downes SM; Cowing JA; Hunt DM; Moore AT; Holder GE
    Retina; 2010 Jan; 30(1):51-62. PubMed ID: 19952985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of retinal structure and function in cone dystrophy with supernormal rod response.
    Abdelkader E; Yasir ZH; Khan AM; Raddadi O; Khandekar R; Alateeq N; Nowilaty S; AlShahrani N; Schatz P
    Doc Ophthalmol; 2020 Aug; 141(1):23-32. PubMed ID: 31960170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel biallelic loss-of-function KCNV2 variants in cone dystrophy with supernormal rod responses.
    Kutsuma T; Katagiri S; Hayashi T; Yoshitake K; Iejima D; Gekka T; Kohzaki K; Mizobuchi K; Baba Y; Terauchi R; Matsuura T; Ueno S; Iwata T; Nakano T
    Doc Ophthalmol; 2019 Jun; 138(3):229-239. PubMed ID: 30877594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound heterozygous KCNV2 variants contribute to cone dystrophy with supernormal rod responses in a Chinese family.
    Liu M; Zhu Y; Huang L; Jiang W; Wu N; Song Y; Lu Y; Ma Y
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1795. PubMed ID: 34535971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypical Characteristics of POC1B-Associated Retinopathy in Japanese Cohort: Cone Dystrophy With Normal Funduscopic Appearance.
    Kameya S; Fujinami K; Ueno S; Hayashi T; Kuniyoshi K; Ideta R; Kikuchi S; Kubota D; Yoshitake K; Katagiri S; Sakuramoto H; Kominami T; Terasaki H; Yang L; Fujinami-Yokokawa Y; Liu X; Arno G; Pontikos N; Miyake Y; Iwata T; Tsunoda K;
    Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3432-3446. PubMed ID: 31390656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cone dystrophy with supernormal rod response: novel KCNV2 mutations in an underdiagnosed phenotype.
    Zelinger L; Wissinger B; Eli D; Kohl S; Sharon D; Banin E
    Ophthalmology; 2013 Nov; 120(11):2338-43. PubMed ID: 23725738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of KCNV2 associated cone dystrophy with supernormal rod electroretinogram and MFRP related oculopathy in a Turkish family.
    Ritter M; Vodopiutz J; Lechner S; Moser E; Schmidt-Erfurth UM; Janecke AR
    Br J Ophthalmol; 2013 Feb; 97(2):169-73. PubMed ID: 23143909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IQCB1 (NPHP5)-Retinopathy: Clinical and Genetic Characterization and Natural History.
    Sen S; Fabozzi L; Fujinami K; Fujinami-Yokokawa YU; Wright GA; Webster A; Mahroo O; Robson AG; Georgiou M; Michaelides M
    Am J Ophthalmol; 2024 Aug; 264():205-215. PubMed ID: 38522724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KCNV2-Associated Retinopathy: Genetics, Electrophysiology, and Clinical Course-KCNV2 Study Group Report 1.
    Georgiou M; Robson AG; Fujinami K; Leo SM; Vincent A; Nasser F; Cabral De Guimarães TA; Khateb S; Pontikos N; Fujinami-Yokokawa Y; Liu X; Tsunoda K; Hayashi T; Vargas ME; Thiadens AAHJ; de Carvalho ER; Nguyen XT; Arno G; Mahroo OA; Martin-Merida MI; Jimenez-Rolando B; Gordo G; Carreño E; Ayuso C; Sharon D; Kohl S; Huckfeldt RM; Wissinger B; Boon CJF; Banin E; Pennesi ME; Khan AO; Webster AR; Zrenner E; Héon E; Michaelides M
    Am J Ophthalmol; 2021 May; 225():95-107. PubMed ID: 33309813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.